Anemia of Chronic Disease: A Comprehensive Guide to Differential Diagnosis

Anemia, characterized by a decrease in hemoglobin, hematocrit, or red blood cell count, is not a disease itself but rather a sign of an underlying medical condition. It is a global health issue, affecting millions and significantly impacting healthcare costs. Defined clinically by hemoglobin levels below 13.5 g/dL for men and 12.0 g/dL for women, anemia reduces the blood’s capacity to carry oxygen, leading to tissue hypoxia. Chronic anemia, in particular, is a common and multifaceted condition arising from various long-term illnesses. Understanding its differential diagnosis is crucial for accurate diagnosis and effective management.

This article provides an in-depth exploration of chronic anemia, focusing on its differential diagnosis. It aims to enhance understanding for healthcare professionals, offering a comprehensive guide to evaluating and distinguishing anemia of chronic disease from other conditions presenting with similar hematological profiles.

Understanding Anemia of Chronic Disease (ACD)

Anemia of chronic disease, also known as anemia of inflammation, is frequently observed in patients with chronic infections, inflammatory conditions, and malignancies. It is distinct from other types of anemia due to its unique pathophysiology rooted in chronic immune activation. While iron deficiency anemia remains the most prevalent form globally, ACD is the most common anemia found in hospitalized individuals.

Etiology and Classification of Anemia

The classification of anemia is often based on the mean corpuscular volume (MCV), which reflects the average size of red blood cells. This categorization helps narrow down the potential causes:

Microcytic Anemias (MCV < 80 fL)

Iron Deficiency Anemia: The most common cause of anemia worldwide, typically due to insufficient iron intake, absorption, or chronic blood loss.
Thalassemia: Inherited blood disorders affecting hemoglobin production.
Anemia of Chronic Disease (in some cases): While typically normocytic, ACD can sometimes present as microcytic, particularly in long-standing inflammation.
Sideroblastic Anemia: A group of disorders characterized by the bone marrow’s inability to produce normal red blood cells, leading to iron accumulation in erythroblasts.

Macrocytic Anemias (MCV > 100 fL)

Vitamin B12 and Folate Deficiency: Essential nutrients for DNA synthesis in red blood cell production.
Alcoholism and Liver Disease: Alcohol can directly suppress bone marrow and liver disease can impair nutrient metabolism.
Myelodysplastic Syndromes (MDS): A group of bone marrow failure disorders.
Drug-Induced: Certain medications can interfere with DNA synthesis or red blood cell maturation.
Hypothyroidism: Thyroid hormones play a role in erythropoiesis.

Normocytic Anemias (MCV 80-100 fL)

Anemia of Chronic Disease (most common presentation): The inflammatory process primarily leads to normocytic anemia.
Bone Marrow Suppression: Conditions like aplastic anemia (bone marrow failure) and myelophthisic anemia (bone marrow replacement by other tissues) reduce red blood cell production.
Early Iron Deficiency Anemia: In the initial stages, iron deficiency may present as normocytic anemia before becoming microcytic.
Hemolytic Anemia: Premature destruction of red blood cells, which can be either macrocytic or normocytic depending on the underlying cause and bone marrow response.

Alt text: Microscopic view of reticulocytes, immature red blood cells, in a peripheral blood smear stained with Romanowsky stain, indicative of hemolytic anemia.

Pathophysiology of Anemia of Chronic Disease

The pathophysiology of ACD is complex and primarily driven by chronic inflammation. The key mediator is hepcidin, an acute-phase reactant hormone produced by the liver. Inflammatory cytokines, such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-1 (IL-1), which are elevated in chronic inflammatory states, stimulate hepcidin production.

Hepcidin disrupts iron homeostasis by:

Reducing Intestinal Iron Absorption: Hepcidin binds to ferroportin, the iron exporter present on enterocytes, macrophages, and hepatocytes. This binding causes ferroportin internalization and degradation, reducing iron release from these cells. Consequently, iron absorption from the gut is decreased.
Impairing Iron Release from Macrophages and Hepatocytes: By blocking ferroportin, hepcidin prevents the release of recycled iron from macrophages and stored iron from hepatocytes. This effectively traps iron within these cells, limiting its availability for erythropoiesis.

In addition to hepcidin, inflammatory cytokines contribute to ACD through other mechanisms:

Suppression of Erythropoiesis: Cytokines can directly inhibit erythroid progenitor cell proliferation and differentiation in the bone marrow, reducing red blood cell production.
Decreased Erythropoietin (EPO) Production and Response: While EPO production is primarily regulated by renal hypoxia, inflammatory cytokines can blunt the EPO response to anemia and may also slightly reduce EPO production by the kidneys.
Increased Red Blood Cell Destruction (Mild Hemolysis): Inflammation can subtly increase red blood cell destruction, although this is usually a minor contributor compared to impaired iron availability and erythropoiesis.

Chronic kidney disease (CKD) is a significant contributor to ACD. Reduced EPO production due to kidney dysfunction is a major factor. However, the inflammatory milieu in CKD also contributes to ACD through hepcidin-mediated iron restriction and blunted erythropoiesis.

Differential Diagnosis of Anemia of Chronic Disease

Anemia of chronic disease is often a diagnosis of exclusion, meaning other causes of anemia, particularly those with similar MCV characteristics, must be ruled out. The differential diagnosis is crucial for guiding appropriate management and avoiding misdiagnosis. The primary challenge lies in differentiating ACD from other normocytic and microcytic anemias.

Differentiating ACD from Other Anemias Based on MCV

1. Microcytic Anemias in the Differential of ACD:

While ACD is typically normocytic, it can sometimes present with microcytosis, especially in cases of long-standing inflammation or when coexisting with iron deficiency. The key microcytic anemias to differentiate from ACD include:

Iron Deficiency Anemia (IDA): This is the most critical differential diagnosis for microcytic anemia.
- Distinguishing Features: Iron studies are crucial. In IDA, serum ferritin is low, serum iron is low, and total iron-binding capacity (TIBC) is high. In ACD, serum ferritin is typically normal to high (acute phase reactant), serum iron is low, and TIBC is low to normal. The transferrin saturation (serum iron/TIBC) is usually low in both conditions but can be more profoundly reduced in IDA. Clinical context is also important; IDA is often associated with obvious blood loss (menorrhagia, gastrointestinal bleeding) or poor dietary intake, while ACD is linked to chronic inflammatory conditions.

Alt text: Illustration depicting iron deficiency anemia, characterized by small, pale red blood cells due to insufficient iron for hemoglobin synthesis.

Thalassemia: Inherited disorders of hemoglobin synthesis, primarily affecting globin chains.
- Distinguishing Features: Thalassemia often presents with microcytosis out of proportion to the degree of anemia. Peripheral blood smear may show target cells and basophilic stippling. Hemoglobin electrophoresis is diagnostic, revealing abnormal hemoglobin fractions (e.g., increased HbA2 in beta-thalassemia trait). Iron studies are usually normal. Ethnicity (Mediterranean, Asian, African descent) is a risk factor.
Sideroblastic Anemia: Disorders characterized by ineffective erythropoiesis and iron accumulation in mitochondria of erythroblasts, forming ring sideroblasts in the bone marrow.
- Distinguishing Features: Sideroblastic anemia can be inherited or acquired (e.g., due to myelodysplastic syndromes, alcohol, drugs like isoniazid, lead poisoning). Iron studies typically show high serum iron and ferritin, and normal to low TIBC (high transferrin saturation). Peripheral smear may show dimorphic red blood cell population (both normochromic and hypochromic cells) and Pappenheimer bodies (iron inclusions). Bone marrow aspirate and biopsy with Prussian blue stain are essential to identify ring sideroblasts.

Alt text: Microscopic image of bone marrow aspirate showing ring sideroblasts, erythroblasts with iron-laden mitochondria encircling the nucleus, a hallmark of sideroblastic anemia.

2. Normocytic Anemias in the Differential of ACD:

ACD most commonly presents as normocytic anemia, making the differential diagnosis broader and requiring careful evaluation. Key normocytic anemias to consider include:

Early Iron Deficiency Anemia: As mentioned earlier, IDA can initially be normocytic before progressing to microcytosis. Repeat iron studies after a period may reveal the typical IDA pattern if initially borderline.
Aplastic Anemia: Bone marrow failure resulting in pancytopenia (anemia, leukopenia, thrombocytopenia).
- Distinguishing Features: Aplastic anemia presents with low reticulocyte count (hypoproliferative anemia) and pancytopenia in the complete blood count (CBC). Bone marrow biopsy is hypocellular. ACD, in contrast, usually has a normal or mildly reduced reticulocyte count (relative to the degree of anemia) and typically does not cause severe pancytopenia.
Myelophthisic Anemia: Anemia caused by bone marrow infiltration by abnormal cells (e.g., metastatic cancer, leukemia, lymphoma, granulomatous disease).
- Distinguishing Features: Peripheral blood smear often shows leukoerythroblastic picture (immature red blood cells and white blood cells), teardrop cells, and may reveal the underlying malignant cells. Bone marrow biopsy is diagnostic, showing marrow infiltration. Clinical history and other findings suggestive of malignancy are important clues.
Hemolytic Anemias: Anemias caused by increased red blood cell destruction.
- Distinguishing Features: Hemolytic anemias are characterized by signs of hemolysis: increased reticulocyte count, elevated indirect bilirubin, elevated lactate dehydrogenase (LDH), and decreased haptoglobin. Direct Coombs test is positive in autoimmune hemolytic anemia. Peripheral smear may show spherocytes, schistocytes, or sickle cells depending on the cause. ACD typically does not present with significant hemolysis or these hemolytic markers.

Alt text: Microscopic image showing hypochromic microcytic anemia, characterized by red blood cells with reduced hemoglobin content and smaller size, often seen in iron deficiency.

3. Macrocytic Anemias:

While ACD is not typically macrocytic, macrocytic anemias should be considered in the broader differential diagnosis of anemia. Vitamin B12 and folate deficiency are the primary macrocytic anemias to exclude. These are usually easily differentiated from ACD based on vitamin levels and MCV.

Other Conditions in the Differential Diagnosis (from Original Article)

The original article also lists renal failure, myxedema coma, adrenal crisis, tuberculosis, and HIV in the differential diagnosis of chronic anemia. These conditions are not necessarily direct mimics of ACD but are important to consider in the broader context of chronic anemia and systemic illnesses:

Renal Failure (Chronic Kidney Disease): CKD is a significant cause of ACD due to reduced EPO production and inflammation. However, anemia in CKD is often multifactorial and can also involve iron deficiency (due to blood loss, reduced absorption), and hemolysis. Differentiating pure EPO-deficient anemia of CKD from ACD in CKD can be challenging. Iron studies and inflammatory markers can help.
Myxedema Coma and Adrenal Crisis: These are endocrine emergencies that can present with various non-specific symptoms, including anemia. The anemia in these conditions is often multifactorial and related to the underlying systemic stress and hormonal imbalances rather than specifically ACD mechanisms. The acute presentation and other clinical features of endocrine crisis will usually distinguish them from typical ACD.
Tuberculosis and HIV: These chronic infections can indeed cause ACD as part of their systemic inflammatory response. However, anemia in these conditions can also be due to other factors like nutritional deficiencies, drug toxicities, or opportunistic infections. In the context of these infections, ACD should be considered as one possible mechanism of anemia, but a comprehensive evaluation is needed to rule out other causes.

Evaluation and Diagnostic Approach to Differentiate ACD

The evaluation of chronic anemia, particularly to differentiate ACD, involves a stepwise approach:

Complete Blood Count (CBC) and Peripheral Blood Smear: Initial assessment to determine the presence and severity of anemia, MCV classification, and red blood cell morphology. Reticulocyte count is crucial to assess bone marrow response.
Iron Studies: Serum iron, ferritin, TIBC, and transferrin saturation are essential to differentiate ACD from IDA and sideroblastic anemia. Remember the typical pattern in ACD: low serum iron, normal to high ferritin, low to normal TIBC.
Inflammatory Markers: C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) can support the diagnosis of ACD by demonstrating ongoing inflammation. However, these are non-specific.
Vitamin B12 and Folate Levels: To rule out macrocytic anemias.
Renal and Liver Function Tests: To assess for underlying organ dysfunction that could contribute to anemia.
Thyroid-Stimulating Hormone (TSH): To exclude hypothyroidism.
Hemoglobin Electrophoresis: If thalassemia is suspected (microcytic anemia, specific ethnicity).
Direct Coombs Test, LDH, Bilirubin, Haptoglobin: If hemolytic anemia is suspected (elevated reticulocyte count, jaundice).
Bone Marrow Aspiration and Biopsy: Reserved for complex cases, unclear diagnoses, or suspicion of bone marrow disorders (sideroblastic anemia, aplastic anemia, myelodysplastic syndromes, myelophthisic anemia). Prussian blue stain for iron is crucial in sideroblastic anemia.
Clinical Context: Thorough history and physical examination are paramount. Identify underlying chronic conditions (infections, inflammatory diseases, malignancies), medications, nutritional status, and potential sources of blood loss.

Conclusion: Navigating the Differential Diagnosis of Anemia of Chronic Disease

Anemia of chronic disease is a common and clinically significant condition, but its diagnosis requires careful consideration of the differential diagnosis. Distinguishing ACD from other anemias, particularly IDA and other normocytic and microcytic anemias, is crucial for appropriate management. A systematic approach involving CBC, iron studies, assessment of inflammatory markers, and consideration of the clinical context is essential. By carefully evaluating these factors, clinicians can accurately diagnose ACD and manage the underlying chronic condition, ultimately improving patient outcomes.

References

Tas F, Eralp Y, Basaran M, Sakar B, Alici S, Argon A, Bulutlar G, Camlica H, Aydiner A, Topuz E. Anemia in oncology practice: relation to diseases and their therapies. Am J Clin Oncol. 2002 Aug;25(4):371-9. PubMed: 12151968
Sachdev V, Rosing DR, Thein SL. Cardiovascular complications of sickle cell disease. Trends Cardiovasc Med. 2021 Apr;31(3):187-193. PMC free article: PMC7417280 PubMed: 32139143
Baradwan S, Alyousef A, Turkistani A. Associations between iron deficiency anemia and clinical features among pregnant women: a prospective cohort study. J Blood Med. 2018;9:163-169. PMC free article: PMC6174908 PubMed: 30323700
Lanier JB, Park JJ, Callahan RC. Anemia in Older Adults. Am Fam Physician. 2018 Oct 01;98(7):437-442. PubMed: 30252420
Kunireddy N, Jacob R, Khan SA, Yadagiri B, Sai Baba KSS, Rajendra Vara Prasad I, Mohan IK. Hepcidin and Ferritin: Important Mediators in Inflammation Associated Anemia in Systemic Lupus Erythematosus Patients. Indian J Clin Biochem. 2018 Oct;33(4):406-413. PMC free article: PMC6170241 PubMed: 30319186
Anand S, Thomas B, Remuzzi G, Riella M, Nahas ME, Naicker S, Dirks J. Kidney Disease. In: Prabhakaran D, Anand S, Gaziano TA, Mbanya JC, Wu Y, Nugent R, editors. Cardiovascular, Respiratory, and Related Disorders. 3rd ed. The International Bank for Reconstruction and Development / The World Bank; Washington (DC): Nov 17, 2017. PubMed: 30212067
Hong CT, Hsieh YC, Liu HY, Chiou HY, Chien LN. Association Between Anemia and Dementia: A Nationwide, Populationbased Cohort Study in Taiwan. Curr Alzheimer Res. 2020;17(2):196-204. PubMed: 32183675
Agbozo F, Abubakari A, Der J, Jahn A. Maternal Dietary Intakes, Red Blood Cell Indices and Risk for Anemia in the First, Second and Third Trimesters of Pregnancy and at Predelivery. Nutrients. 2020 Mar 15;12(3) PMC free article: PMC7146471 PubMed: 32183478
Ray JG, Davidson A, Berger H, Dayan N, Park AL. Haemoglobin levels in early pregnancy and severe maternal morbidity: population-based cohort study. BJOG. 2020 Aug;127(9):1154-1164. PubMed: 32175668